| Solid lipid nanoparticles and nanostructured lipid carriers: structure, preparation and application N Naseri, H Valizadeh, P Zakeri-Milani Advanced pharmaceutical bulletin 5 (3), 305, 2015 | 1071 | 2015 |
| Predicting human intestinal permeability using single-pass intestinal perfusion in rat P Zakeri-Milani, H Valizadeh, H Tajerzadeh, Y Azarmi, Z Islambolchilar, ... Journal of Pharmacy and Pharmaceutical Sciences 10 (3), 368-379, 2007 | 264 | 2007 |
| Liposome and immune system interplay: Challenges and potentials F Zahednezhad, M Saadat, H Valizadeh, P Zakeri-Milani, B Baradaran Journal of Controlled Release 305, 194-209, 2019 | 227 | 2019 |
| Physicochemical characterization of solid dispersions of indomethacin with PEG 6000, Myrj 52, lactose, sorbitol, dextrin, and Eudragit® E100 H Valizadeh, A Nokhodchi, N Qarakhani, P Zakeri‐Milani, S Azarmi, ... Drug development and industrial pharmacy 30 (3), 303-317, 2004 | 187 | 2004 |
| Biopharmaceutical classification of drugs using intrinsic dissolution rate (IDR) and rat intestinal permeability P Zakeri-Milani, M Barzegar-Jalali, M Azimi, H Valizadeh European journal of pharmaceutics and biopharmaceutics 73 (1), 102-106, 2009 | 172 | 2009 |
| Simultaneous determination of naproxen, ketoprofen and phenol red in samples from rat intestinal permeability studies: HPLC method development and validation P Zakeri-Milani, M Barzegar-Jalali, H Tajerzadeh, Y Azarmi, H Valizadeh Journal of pharmaceutical and biomedical analysis 39 (3-4), 624-630, 2005 | 161 | 2005 |
| The characteristics and improved intestinal permeability of vancomycin PLGA-nanoparticles as colloidal drug delivery system P Zakeri-Milani, BD Loveymi, M Jelvehgari, H Valizadeh Colloids and Surfaces B: Biointerfaces 103, 174-181, 2013 | 136 | 2013 |
| Preparation and characterization of solid dispersions of piroxicam with hydrophilic carriers H Valizadeh, P Zakeri-Milani, M Barzegar-Jalali, G Mohammadi, ... Drug development and industrial pharmacy 33 (1), 45-56, 2007 | 107 | 2007 |
| Overview on experimental models of interactions between nanoparticles and the immune system S Najafi-Hajivar, P Zakeri-Milani, H Mohammadi, M Niazi, ... Biomedicine & Pharmacotherapy 83, 1365-1378, 2016 | 106 | 2016 |
| Development of pH-sensitive insulin nanoparticles using Eudragit L100-55 and chitosan with different molecular weights M Jelvehgari, P Zakeri-Milani, MR Siahi-Shadbad, BD Loveymi, ... Aaps Pharmscitech 11, 1237-1242, 2010 | 102 | 2010 |
| Application of response surface methodology in development of sirolimus liposomes prepared by thin film hydration technique S Ghanbarzadeh, H Valizadeh, P Zakeri-Milani BioImpacts: BI 3 (2), 75, 2013 | 94 | 2013 |
| An update on actively targeted liposomes in advanced drug delivery to glioma S Mojarad-Jabali, M Farshbaf, PR Walker, S Hemmati, Y Fatahi, ... International Journal of Pharmaceutics 602, 120645, 2021 | 93 | 2021 |
| The effects of lyophilization on the physico-chemical stability of sirolimus liposomes S Ghanbarzadeh, H Valizadeh, P Zakeri-Milani Advanced pharmaceutical bulletin 3 (1), 25, 2013 | 92 | 2013 |
| Axial pharmaceutical properties of liposome in cancer therapy: Recent advances and perspectives SH Kiaie, S Mojarad-Jabali, F Khaleseh, S Allahyari, E Taheri, ... International journal of pharmaceutics 581, 119269, 2020 | 87 | 2020 |
| Intestinal transporters: enhanced absorption through P-glycoprotein-related drug interactions P Zakeri-Milani, H Valizadeh Expert opinion on drug metabolism & toxicology 10 (6), 859-871, 2014 | 86 | 2014 |
| Preparation and evaluation of PCL-PEG-PCL micelles as potential nanocarriers for ocular delivery of dexamethasone M Alami-Milani, P Zakeri-Milani, H Valizadeh, R Salehi, M Jelvehgari Iranian journal of basic medical sciences 21 (2), 153, 2018 | 84 | 2018 |
| Antibacterial effect of diclofenac sodium on Enterococcus faecalis A Salem-Milani, E Balaei-Gajan, S Rahimi, Z Moosavi, A Abdollahi, ... Journal of dentistry (Tehran, Iran) 10 (1), 16, 2013 | 84 | 2013 |
| Anti-bacterial performance of azithromycin nanoparticles as colloidal drug delivery system against different gram-negative and gram-positive bacteria M Azhdarzadeh, F Lotfipour, P Zakeri-Milani, G Mohammadi, H Valizadeh Advanced pharmaceutical bulletin 2 (1), 17, 2012 | 74 | 2012 |
| The latest advances of cisplatin liposomal formulations: essentials for preparation and analysis F Zahednezhad, P Zakeri-Milani, J Shahbazi Mojarrad, H Valizadeh Expert opinion on drug delivery 17 (4), 523-541, 2020 | 72 | 2020 |
| Drug targeting strategies based on charge dependent uptake of nanoparticles into cancer cells M Saadat, F Zahednezhad, P Zakeri-Milani, HR Heidari, ... Journal of Pharmacy & Pharmaceutical Sciences 22, 191-220, 2019 | 69 | 2019 |
Hadi ValizadehProfessor of Pharmaceutics, Tabriz University of Medical SciencesVerified email at tbzmed.ac.ir